BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20025035)

  • 1. Detrusor myocyte activity and afferent signaling.
    Andersson KE
    Neurourol Urodyn; 2010; 29(1):97-106. PubMed ID: 20025035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimuscarinics and overactive bladder: other mechanism of action.
    Yamaguchi O
    Neurourol Urodyn; 2010; 29(1):112-5. PubMed ID: 19693952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-A.
    Kanai A; Wyndaele JJ; Andersson KE; Fry C; Ikeda Y; Zabbarova I; De Wachter S
    Neurourol Urodyn; 2011 Jun; 30(5):684-91. PubMed ID: 21661014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of bladder function by peripheral nerves: avenues for novel drug targets.
    Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
    Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats.
    Yokoyama O
    Neurourol Urodyn; 2010; 29(1):107-11. PubMed ID: 20025014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into new potential targets for the treatment of overactive bladder and detrusor overactivity.
    Cerruto MA; Asimakopoulos AD; Artibani W; Del Popolo G; La Martina M; Carone R; Finazzi-Agrò E
    Urol Int; 2012; 89(1):1-8. PubMed ID: 22738896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does altered myogenic activity contribute to OAB symptoms from detrusor overactivity? ICI-RS 2013.
    Chacko S; Cortes E; Drake MJ; Fry CH
    Neurourol Urodyn; 2014 Jun; 33(5):577-80. PubMed ID: 24838314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower urinary tract symptoms (LUTS) and bladder afferent activity.
    Yoshimura N
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):908-13. PubMed ID: 17654565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimuscarinic mechanisms and the overactive detrusor: an update.
    Andersson KE
    Eur Urol; 2011 Mar; 59(3):377-86. PubMed ID: 21168951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
    Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
    Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Ca2+ oscillations in smooth muscle cells from overactive human bladders.
    Sui G; Fry CH; Malone-Lee J; Wu C
    Cell Calcium; 2009 May; 45(5):456-64. PubMed ID: 19345414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the potassium channel opener WAY-133537 on the overactive bladder of spinalized rats.
    Elzayat E; Khaled S; Kashiwabara T; Elhilali M; Corcos J
    Neurourol Urodyn; 2006; 25(7):808-14. PubMed ID: 16804922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afferent mechanism in the urinary tract.
    Kanai AJ
    Handb Exp Pharmacol; 2011; (202):171-205. PubMed ID: 21290227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle.
    Imamura M; Negoro H; Kanematsu A; Yamamoto S; Kimura Y; Nagane K; Yamasaki T; Kanatani I; Ito N; Tabata Y; Ogawa O
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F46-54. PubMed ID: 19386724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mechanical stretch on interstitial cells of Cajal in guinea pig bladder.
    Wang Y; Fang Q; Lu Y; Song B; Li W; Li L
    J Surg Res; 2010 Nov; 164(1):e213-9. PubMed ID: 20828727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The afferent system and its role in lower urinary tract dysfunction.
    Daly DM; Collins VM; Chapple CR; Grundy D
    Curr Opin Urol; 2011 Jul; 21(4):268-74. PubMed ID: 21537194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.
    Christ GJ; Hodges S
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S41-55. PubMed ID: 16465183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targets for overactive bladder other than smooth muscle.
    Michel MC; Igawa Y
    Expert Opin Ther Targets; 2015 May; 19(5):687-705. PubMed ID: 25704500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of electrical stimulation of the striatum on bladder activity in cats.
    Yamamoto T; Sakakibara R; Nakazawa K; Uchiyama T; Shimizu E; Hattori T
    Neurourol Urodyn; 2009; 28(6):549-54. PubMed ID: 19214990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial cells in the urinary bladder--localization and function.
    McCloskey KD
    Neurourol Urodyn; 2010; 29(1):82-7. PubMed ID: 20025023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.